Literature DB >> 9534852

Evaluation of myocardial ischemia in Kawasaki disease by dobutamine stress signal-averaged ventricular late potentials.

Y Genma1, S Ogawa, J Zhang, M Yamamoto.   

Abstract

OBJECTIVE: To determine the possibility of diagnosing myocardial ischemia from signal-averaged electrocardiographic late potentials (LPs) in patients with Kawasaki disease.
METHODS: Dobutamine stress LPs were obtained in 85 children with a history of Kawasaki disease (48 without coronary artery lesions, 19 with coronary artery lesions without myocardial ischemia, and 18 with myocardial ischemia). The infusion of dobutamine was started at 5 micrograms/kg/min, increased to 30 micrograms/kg/min. The presence of LPs was determined by the filtered QRS duration, the root mean square voltage during the last 40 ms, and the duration of the signal under 40 microV.
RESULTS: Among the children without coronary lesions, LPs were detected in 4.2% at rest and in 2.1% with dobutamine stress. Among the group with coronary lesions but without ischemia, LPs were found in 5.3% at rest and in 5.3% with stress. In the group with ischemia, LPs were present in 44.4% at rest and in 77.8% with stress. The sensitivity for myocardial ischemia was 72.7% at rest and 87.5% with stress (p < 0.05), and the specificity was 86.5% at rest and 94.2% with stress.
CONCLUSION: LPs associated with dobutamine stress testing are useful for identifying myocardial ischemia in children with Kawasaki disease, especially in those who cannot tolerate testing involving physical exercise.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9534852     DOI: 10.1016/s0008-6363(97)00196-x

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  2 in total

1.  Lack of impact of myocardial ischemia on the signal-averaged ECG assessment by time-domain analysis.

Authors:  Michael A E Schneider; Christoph A Nienaber
Journal:  Ann Noninvasive Electrocardiol       Date:  2002-07       Impact factor: 1.468

2.  Dobutamine stress echocardiography in the evaluation of young patients with Kawasaki disease.

Authors:  M V Zilberman; G Goya; S A Witt; B Glascock; T R Kimball
Journal:  Pediatr Cardiol       Date:  2003-01-15       Impact factor: 1.655

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.